Eroluz C Cream contains Ciclopirox 1% w/w, an antifungal agent indicated for the topical treatment of superficial fungal infections of the skin, including dermatophytosis, candidiasis, and pityriasis versicolor. Ciclopirox exhibits broad-spectrum antifungal activity by inhibiting the transport of essential elements in fungal cells, leading to the disruption of cellular metabolism and growth. Eroluz C Cream is effective against a variety of dermatophytes, yeasts, and some gram-positive bacteria, making it suitable for mixed infections. The cream formulation allows for easy application and ensures adequate skin penetration, promoting rapid resolution of symptoms such as erythema, scaling, itching, and inflammation. It is typically applied once or twice daily to the affected area and surrounding skin after cleansing, with treatment duration varying according to the type and severity of infection, generally ranging from 2 to 4 weeks. Eroluz C Cream is well tolerated, with minimal adverse effects; occasional local irritation or burning sensation may occur. It is contraindicated in patients with known hypersensitivity to Ciclopirox or any cream excipients. Use during pregnancy and lactation should be under medical supervision. Proper adherence to the prescribed regimen is essential to prevent recurrence and resistance development.